Pfizer submits regulatory filings against Revatio (sildenafil citrate) as a treatment on pulmonary arterial hypertension

January 18th, 2010

has announced it has submitted regulatory filings in the Common States and Europe in favour of Revatio (sildenafil citrate) as a treatment to save pulmonary arterial hypertension (PAH), a rare, hostile and life-shortening vascular affliction. Sildenafil is the agile ingredient in Viagra, Pfizer‘s erectile dysfunction medication worn in the main more than 23 million men [...]

Tags: , , , , , , , , , , , ,
Posted in Viagra News | Comments (16)

Recent Posts